Biomea Fusion

+$0.61 (+11.73%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biomea Fusion and other ETFs, options, and stocks.

About BMEA

Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in Redwood City, CA.

CEO
Thomas Butler
Employees
51
Headquarters
Redwood City, California
Founded
2017

BMEA Key Statistics

Market cap
169.47M
Price-Earnings ratio
—
Dividend yield
—
Average volume
307.26K
High today
$5.82
Low today
$5.22
Open price
$5.47
Volume
78.42K
52 Week high
$21.48
52 Week low
$2.84

BMEA Earnings

-$0.56
-$0.37
-$0.19
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.53 per share
Actual
-$0.56 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure